PT-2026-50821 · Apollo Pharmacy · Blood Glucose Monitoring System

Rishitha Pucchakayala · Publicado 2026-06-18 · Atualizado 2026-06-19 · CVE-2026-50034

NVD

CVSS v3.1

6.5

Média

Vetor base

AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

Correção

Cleartext Transmission of Sensitive Information

Enumeração de Fraquezas

CWE-319

Identificadores relacionados

CVE-2026-50034

Produtos afetados

Blood Glucose Monitoring System

Referências · 6

• https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json · Nota
• https://apollopharmacy.in/contact-us · Nota
• https://cisa.gov/news-events/news/understanding-bluetooth-technology · Nota
• https://nvd.nist.gov/vuln/detail/CVE-2026-50034 · Nota de Segurança
• https://twitter.com/aviatrixtrc/status/2068017667823255702 · Publicação no Twitter
• https://cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01 · Nota